149 related articles for article (PubMed ID: 25154566)
1. Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings.
Lurie F; Vaidya V; Comerota AJ
J Vasc Surg; 2015 Jan; 61(1):138-46. PubMed ID: 25154566
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of Initial Treatment Strategies for Nonembolic Acute Limb Ischemia Using Real-Word Data.
Vaidya V; Gangan N; Comerota A; Lurie F
Ann Vasc Surg; 2017 Feb; 39():276-283. PubMed ID: 27575302
[TBL] [Abstract][Full Text] [Related]
3. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
4. The Readmission Event after Vascular Surgery: Causes and Costs.
Duwayri Y; Goss J; Knechtle W; Veeraswamy RK; Arya S; Rajani RR; Brewster LP; Dodson TF; Sweeney JF
Ann Vasc Surg; 2016 Oct; 36():7-12. PubMed ID: 27321981
[TBL] [Abstract][Full Text] [Related]
5. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of vascular readmissions after common vascular procedures.
Orr NT; El-Maraghi S; Korosec RL; Davenport DL; Xenos ES
J Vasc Surg; 2015 Nov; 62(5):1281-7.e1. PubMed ID: 26251167
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, treatment, and outcomes of acute limb ischemia in the pediatric population.
Lim S; Javorski MJ; Halandras PM; Kuo PC; Aulivola B; Crisostomo P
J Vasc Surg; 2018 Jul; 68(1):182-188. PubMed ID: 29502995
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of the treatments for critical limb ischemia in the elderly population.
Peters CML; de Vries J; Redeker S; Timman R; Eijck GV; Steunenberg SL; Verbogt N; Ho GH; van Busschbach JJ; van der Laan L
J Vasc Surg; 2019 Aug; 70(2):530-538.e1. PubMed ID: 30922757
[TBL] [Abstract][Full Text] [Related]
9. Preventable Complications Driving Rising Costs in Management of Patients with Critical Limb Ischemia.
Dua A; Desai SS; Patel B; Seabrook GR; Brown KR; Lewis B; Rossi PJ; Malinowski M; Lee CJ
Ann Vasc Surg; 2016 May; 33():144-8. PubMed ID: 26916348
[TBL] [Abstract][Full Text] [Related]
10. Discussion.
Dalman RL; Lurie F
J Vasc Surg; 2015 Jan; 61(1):146. PubMed ID: 25154563
[No Abstract] [Full Text] [Related]
11. Risk factors for readmission after lower extremity procedures for peripheral artery disease.
Vogel TR; Kruse RL
J Vasc Surg; 2013 Jul; 58(1):90-7.e1-4. PubMed ID: 23541547
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of lower extremity arterial revascularization economic analyses.
Moriarty JP; Murad MH; Shah ND; Prasad C; Montori VM; Erwin PJ; Forbes TL; Meissner MH; Stoner MC;
J Vasc Surg; 2011 Oct; 54(4):1131-1144.e1. PubMed ID: 21971093
[TBL] [Abstract][Full Text] [Related]
13. The pros and cons of endovascular and open surgical treatments for patients with acute limb ischemia.
Branco BC; Montero-Baker MF; Mills JL
J Cardiovasc Surg (Torino); 2015 Jun; 56(3):401-7. PubMed ID: 25573443
[TBL] [Abstract][Full Text] [Related]
14. Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population.
Indes JE; Mandawat A; Tuggle CT; Muhs B; Sosa JA
J Vasc Surg; 2010 Nov; 52(5):1173-9, 1179.e1. PubMed ID: 20691560
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of revascularization for limb preservation in patients with marginal functional status.
Barshes NR; Kougias P; Ozaki CK; Pisimisis G; Bechara CF; Henson HK; Belkin M
Ann Vasc Surg; 2014 Jan; 28(1):10-7. PubMed ID: 24332257
[TBL] [Abstract][Full Text] [Related]
17. Part two: against the motion. endovascular therapy is the preferred treatment for patients <65 years old with symptomatic infrainguinal arterial disease.
Houbballah R; Raux M; LaMuraglia G
Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):116-9. PubMed ID: 22878046
[No Abstract] [Full Text] [Related]
18. Safety and Effectiveness of Adjunctive Intra-Arterial Abciximab in the Management of Acute Limb Ischemia.
Salzler GG; Graham A; Connolly PH; Schneider DB; Meltzer AJ
Ann Vasc Surg; 2016 Jan; 30():66-71. PubMed ID: 26476269
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis of endovascular and surgical revascularization techniques in acute limb ischemia.
Veenstra EB; van der Laan MJ; Zeebregts CJ; de Heide EJ; Kater M; Bokkers RPH
J Vasc Surg; 2020 Feb; 71(2):654-668.e3. PubMed ID: 31353270
[TBL] [Abstract][Full Text] [Related]
20. Thoracic aortic trauma: outcomes and hospital resource utilization after endovascular and open repair.
Mousa AY; Dombrovskiy VY; Haser PB; Graham AM; Vogel TR
Vascular; 2010; 18(5):250-5. PubMed ID: 20822718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
